164 related articles for article (PubMed ID: 29137409)
1. Overexpression of CTEN relates to tumor malignant potential and poor outcomes of adenocarcinoma of the esophagogastric junction.
Aratani K; Komatsu S; Ichikawa D; Ohashi T; Miyamae M; Okajima W; Imamura T; Kiuchi J; Nishibeppu K; Kosuga T; Konishi H; Shiozaki A; Fujiwara H; Okamoto K; Tsuda H; Otsuji E
Oncotarget; 2017 Oct; 8(48):84112-84122. PubMed ID: 29137409
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of YWHAZ as an independent prognostic factor in adenocarcinoma of the esophago-gastric junction.
Watanabe N; Komatsu S; Ichikawa D; Miyamae M; Ohashi T; Okajima W; Kosuga T; Konishi H; Shiozaki A; Fujiwara H; Okamoto K; Tsuda H; Otsuji E
Am J Cancer Res; 2016; 6(11):2729-2736. PubMed ID: 27904785
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of EGFR as an Independent Prognostic Factor in Adenocarcinoma of the Esophagogastric Junction.
Aratani K; Komatsu S; Ichikawa D; Ohashi T; Miyamae M; Okajima W; Imamura T; Kiuchi J; Nishibeppu K; Kosuga T; Konishi H; Shiozaki A; Fujiwara H; Okamoto K; Tsuda H; Otsuji E
Anticancer Res; 2017 Jun; 37(6):3129-3135. PubMed ID: 28551654
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of denticleless E3 ubiquitin protein ligase homolog (DTL) is related to poor outcome in gastric carcinoma.
Kobayashi H; Komatsu S; Ichikawa D; Kawaguchi T; Hirajima S; Miyamae M; Okajima W; Ohashi T; Kosuga T; Konishi H; Shiozaki A; Fujiwara H; Okamoto K; Tsuda H; Otsuji E
Oncotarget; 2015 Nov; 6(34):36615-24. PubMed ID: 26472028
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of ZRF1 is related to tumor malignant potential and a poor outcome of gastric carcinoma.
Imamura T; Komatsu S; Ichikawa D; Miyamae M; Okajima W; Ohashi T; Kiuchi J; Nishibeppu K; Kosuga T; Konishi H; Shiozaki A; Fujiwara H; Okamoto K; Tsuda H; Otsuji E
Carcinogenesis; 2018 Feb; 39(2):263-271. PubMed ID: 29228320
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of YEATS4 contributes to malignant outcomes in gastric carcinoma.
Kiuchi J; Komatsu S; Imamura T; Nishibeppu K; Shoda K; Arita T; Kosuga T; Konishi H; Shiozaki A; Kubota T; Okamoto K; Fujiwara H; Ichikawa D; Tsuda H; Otsuji E
Am J Cancer Res; 2018; 8(12):2436-2452. PubMed ID: 30662802
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of YWHAZ relates to tumor cell proliferation and malignant outcome of gastric carcinoma.
Nishimura Y; Komatsu S; Ichikawa D; Nagata H; Hirajima S; Takeshita H; Kawaguchi T; Arita T; Konishi H; Kashimoto K; Shiozaki A; Fujiwara H; Okamoto K; Tsuda H; Otsuji E
Br J Cancer; 2013 Apr; 108(6):1324-31. PubMed ID: 23422756
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of PBK/TOPK relates to tumour malignant potential and poor outcome of gastric carcinoma.
Ohashi T; Komatsu S; Ichikawa D; Miyamae M; Okajima W; Imamura T; Kiuchi J; Kosuga T; Konishi H; Shiozaki A; Fujiwara H; Okamoto K; Tsuda H; Otsuji E
Br J Cancer; 2017 Jan; 116(2):218-226. PubMed ID: 27898655
[TBL] [Abstract][Full Text] [Related]
9. TRIM37 contributes to malignant outcomes and CDDP resistance in gastric cancer.
Nishibeppu K; Komatsu S; Kiuchi J; Kishimoto T; Takashima Y; Shoda K; Arita T; Kosuga T; Konishi H; Shiozaki A; Kubota T; Okamoto K; Fujiwara H; Tsuda H; Otsuji E
J Cancer; 2021; 12(2):316-325. PubMed ID: 33391428
[No Abstract] [Full Text] [Related]
10. Overexpression of SMYD2 contributes to malignant outcome in gastric cancer.
Komatsu S; Ichikawa D; Hirajima S; Nagata H; Nishimura Y; Kawaguchi T; Miyamae M; Okajima W; Ohashi T; Konishi H; Shiozaki A; Fujiwara H; Okamoto K; Tsuda H; Imoto I; Inazawa J; Otsuji E
Br J Cancer; 2015 Jan; 112(2):357-64. PubMed ID: 25321194
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of TRIM44 contributes to malignant outcome in gastric carcinoma.
Kashimoto K; Komatsu S; Ichikawa D; Arita T; Konishi H; Nagata H; Takeshita H; Nishimura Y; Hirajima S; Kawaguchi T; Shiozaki A; Fujiwara H; Okamoto K; Tsuda H; Otsuji E
Cancer Sci; 2012 Nov; 103(11):2021-6. PubMed ID: 22862969
[TBL] [Abstract][Full Text] [Related]
12. Comparison of mediastinal lymph node metastases from adenocarcinoma of the esophagogastric junction versus lower esophageal squamous cell carcinoma with involvement of the esophagogastric junction.
Mine S; Watanabe M; Kumagai K; Okamura A; Yuda M; Hayami M; Yamashita K; Imamura Y; Ishizuka N
Dis Esophagus; 2019 Dec; 32(11):. PubMed ID: 30791046
[TBL] [Abstract][Full Text] [Related]
13. Characteristics of lymph node (No.5 and No.6) metastasis and significance of lymph node dissection in Siewert type II esophagogastric junction adenocarcinoma (AEG): No.5 and No.6 lymph node metastases of AEG and clearance.
Zhang X; He XD; Zhang YC; Yang KH; Tian JH; Chen YL
Medicine (Baltimore); 2021 Sep; 100(35):e27106. PubMed ID: 34477150
[TBL] [Abstract][Full Text] [Related]
14. HN1L promotes invasion and metastasis of the esophagogastric junction adenocarcinoma.
Wang ZY; Xiao W; Jiang YZ; Dong W; Zhang XW; Zhang L
Thorac Cancer; 2021 Mar; 12(5):650-658. PubMed ID: 33471419
[TBL] [Abstract][Full Text] [Related]
15. CTEN (C-terminal tensin-like), a novel oncogene overexpressed in invasive breast carcinoma of poor prognosis.
Albasri A; Aleskandarany M; Benhasouna A; Powe DG; Ellis IO; Ilyas M; Green AR
Breast Cancer Res Treat; 2011 Feb; 126(1):47-54. PubMed ID: 20390342
[TBL] [Abstract][Full Text] [Related]
16. Frequency and clinical impact of lymph node micrometastasis and tumor cell microinvolvement in patients with adenocarcinoma of the esophagogastric junction.
Mueller JD; Stein HJ; Oyang T; Natsugoe S; Feith M; Werner M; Rüdiger Siewert J
Cancer; 2000 Nov; 89(9):1874-82. PubMed ID: 11064343
[TBL] [Abstract][Full Text] [Related]
17. [Comparison of clinicopathological features and prognosis between adenocarcinoma of esophagogastric junction and adenocarcinoma of gastric antrum].
Zhu Z; Wang Y; Li F; Gao J; Han B; Wang R; Xue Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Feb; 22(2):149-155. PubMed ID: 30799537
[TBL] [Abstract][Full Text] [Related]
18. p-MEK expression predicts prognosis of patients with adenocarcinoma of esophagogastric junction (AEG) and plays a role in anti-AEG efficacy of Huaier.
Yuan L; Mo SW; Xu ZY; Lv H; Xu JL; Guo KB; Hu C; Wang XF; Chen GP; Qin JJ; Cheng XD
Pharmacol Res; 2021 Mar; 165():105411. PubMed ID: 33401002
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical Expression of Tensin-4/CTEN in Squamous Cell Carcinoma in Dogs.
Monteiro A; Delgado L; Monteiro L; Pires I; Prada J; Raposo T
Vet Sci; 2023 Jan; 10(2):. PubMed ID: 36851390
[TBL] [Abstract][Full Text] [Related]
20. Adenocarcinoma of the esophagogastric junction: the pattern of metastatic lymph node dissemination as a rationale for elective lymphatic target volume definition.
Meier I; Merkel S; Papadopoulos T; Sauer R; Hohenberger W; Brunner TB
Int J Radiat Oncol Biol Phys; 2008 Apr; 70(5):1408-17. PubMed ID: 18374226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
